HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer-Reference-Cited by-同舟云学术

HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer

Published:2021-01-19 Issue:4 Volume:15 Page:1005-1023
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Lombardi Rita¹^ORCID,Sonego Maura²^ORCID,Pucci Biagio¹^ORCID,Addi Laura¹^ORCID,Iannelli Federica¹^ORCID,Capone Francesca¹^ORCID,Alfano Luigi³^ORCID,Roca Maria Serena¹^ORCID,Milone Maria Rita¹,Moccia Tania¹^ORCID,Costa Alice²⁴,Di Gennaro Elena¹^ORCID,Bruzzese Francesca¹^ORCID,Baldassarre Gustavo²^ORCID,Budillon Alfredo¹^ORCID

Affiliation:

1. Experimental Pharmacology Unit‐Laboratories of Naples and Mercogliano (AV) Istituto Nazionale per lo Studio e la Cura dei Tumori “Fondazione G. Pascale” – IRCCS Naples Italy

2. Division of Molecular Oncology Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy

3. Cell Biology and Biotherapy Unit Istituto Nazionale Tumori ‐ IRCCS, Fondazione G. Pascale Naples Italy

4. University of Trieste Italy

Funder

Regione Autonoma Friuli Venezia Giulia

Regione Campania

Associazione Italiana per la Ricerca sul Cancro

Ministero della Salute

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology